{"url_path":"/sec/pths/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1919246/0001919246-26-000070-index.html","accession_number":"0001919246-26-000070","cik":"0001919246","ticker":"PTHS","issuer_name":"Pelthos Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1919246/0001919246-26-000070-index.html","primary_entity_key":"0001919246","primary_entity_name":"Pelthos Therapeutics Inc."},"word_count":568,"has_tables":true,"body_markdown":"pths-20260331\nfalseQ12026--12-3100019192460.10.011230.110.1xbrli:sharesiso4217:USDiso4217:USDxbrli:sharespths:productxbrli:purepths:investorpths:lenderpths:agreementpths:segmentpths:contingentMilestonepths:netSaleAchievmentpths:acquiredProductpths:paymentpths:tradingDaypths:consecutiveTradingDayutr:Ypths:patentutr:sqftpths:option00019192462026-01-012026-03-3100019192462026-05-1100019192462026-03-3100019192462025-12-310001919246us-gaap:SeriesAPreferredStockMember2026-03-310001919246us-gaap:SeriesAPreferredStockMember2025-12-310001919246us-gaap:SeriesCPreferredStockMember2025-12-310001919246us-gaap:SeriesCPreferredStockMember2026-03-310001919246pths:NetProductMember2026-01-012026-03-310001919246pths:NetProductMember2025-01-012025-03-310001919246pths:LicenseAndCollaborationMember2026-01-012026-03-310001919246pths:LicenseAndCollaborationMember2025-01-012025-03-3100019192462025-01-012025-03-310001919246us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-12-310001919246us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2025-12-310001919246us-gaap:CommonStockMember2025-12-310001919246us-gaap:AdditionalPaidInCapitalMember2025-12-310001919246us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001919246us-gaap:RetainedEarningsMember2025-12-310001919246us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001919246us-gaap:CommonStockMember2026-01-012026-03-310001919246us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-03-310001919246us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001919246us-gaap:RetainedEarningsMember2026-01-012026-03-310001919246us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2026-03-310001919246us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2026-03-310001919246us-gaap:CommonStockMember2026-03-310001919246us-gaap:AdditionalPaidInCapitalMember2026-03-310001919246us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001919246us-gaap:RetainedEarningsMember2026-03-310001919246us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2024-12-310001919246us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2024-12-310001919246us-gaap:CommonStockMember2024-12-310001919246us-gaap:AdditionalPaidInCapitalMember2024-12-310001919246us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001919246us-gaap:RetainedEarningsMember2024-12-3100019192462024-12-310001919246us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001919246us-gaap:CommonStockMember2025-01-012025-03-310001919246us-gaap:RetainedEarningsMember2025-01-012025-03-310001919246us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2025-03-310001919246us-gaap:SeriesCPreferredStockMemberus-gaap:PreferredStockMember2025-03-310001919246us-gaap:CommonStockMember2025-03-310001919246us-gaap:AdditionalPaidInCapitalMember2025-03-310001919246us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001919246us-gaap:RetainedEarningsMember2025-03-3100019192462025-03-310001919246us-gaap:IPOMember2024-02-212024-02-210001919246us-gaap:IPOMember2024-02-210001919246pths:LNHCInc.Member2025-07-010001919246pths:LNHCInc.Memberus-gaap:SeriesAPreferredStockMemberpths:LigandMember2025-07-012025-07-010001919246us-gaap:ConvertiblePreferredStockMemberpths:SecuritiesPurchaseAgreementsMember2025-07-012025-07-010001919246us-gaap:ConvertiblePreferredStockMemberpths:SecuritiesPurchaseAgreementsMember2025-07-010001919246pths:SecuritiesPurchaseAgreementsMember2025-07-012025-07-010001919246us-gaap:RelatedPartyMemberus-gaap:NotesPayableOtherPayablesMemberpths:SecuritiesPurchaseAgreementsMember2025-07-012025-07-010001919246pths:SecuritiesPurchaseAgreementsMember2025-07-010001919246us-gaap:PreferredClassAMember2025-07-010001919246us-gaap:SeriesAPreferredStockMember2025-06-300001919246us-gaap:SeriesAPreferredStockMember2025-07-010001919246pths:LigandMemberus-gaap:SeriesAPreferredStockMember2025-07-010001919246us-gaap:SeriesAPreferredStockMemberpths:PIPEInvestorsMembersrt:MinimumMember2025-07-010001919246us-gaap:SeriesAPreferredStockMemberpths:PIPEInvestorsMembersrt:MaximumMember2025-07-010001919246us-gaap:SeriesAPreferredStockMember2025-07-012025-07-010001919246us-gaap:CommonStockMember2025-07-012025-07-010001919246pths:CompanysSecurityHoldersPriorToMergerMember2025-07-012025-07-010001919246pths:LNHCSecurityHoldersPriorToMergerMember2025-07-012025-07-010001919246us-gaap:BridgeLoanMemberpths:LigandFacilityMemberus-gaap:LineOfCreditMember2025-01-010001919246us-gaap:BridgeLoanMemberpths:LigandFacilityMemberus-gaap:LineOfCreditMember2025-07-010001919246us-gaap:BridgeLoanMemberpths:ThirdPartyFacilityMemberus-gaap:LineOfCreditMember2025-04-160001919246us-gaap:RelatedPartyMember2025-07-012025-07-010001919246pths:ThirdPartyFacilityMemberus-gaap:NotesPayableOtherPayablesMember2025-07-012025-07-0100019192462025-07-012025-07-010001919246us-gaap:SecuredDebtMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberus-gaap:LineOfCreditMember2026-01-122026-01-120001919246us-gaap:SecuredDebtMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberus-gaap:LineOfCreditMember2026-01-120001919246pths:ThreeCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2026-01-012026-03-310001919246pths:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2026-01-012026-03-310001919246pths:CustomerTwoMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2026-01-012026-03-310001919246pths:CustomerThreeMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2026-01-012026-03-310001919246pths:ThreeCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-03-310001919246pths:CustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-03-310001919246pths:CustomerTwoMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-03-310001919246pths:CustomerThreeMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-03-310001919246us-gaap:ComputerEquipmentMember2026-03-310001919246srt:MinimumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2026-03-310001919246srt:MaximumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2026-03-310001919246srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2026-03-310001919246srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2026-03-310001919246pths:ManufacturingAndLaboratoryEquipmentMember2026-03-310001919246us-gaap:ConvertibleNotesPayableMember2026-01-012026-03-310001919246us-gaap:ConvertibleNotesPayableMember2025-01-012025-03-310001919246us-gaap:SeriesAPreferredStockMember2026-01-012026-03-310001919246us-gaap:SeriesAPreferredStockMember2025-01-012025-03-310001919246us-gaap:SeriesCPreferredStockMember2026-01-012026-03-310001919246us-gaap:SeriesCPreferredStockMember2025-01-012025-03-310001919246us-gaap:WarrantMember2026-01-012026-03-310001919246us-gaap:WarrantMember2025-01-012025-03-310001919246us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001919246us-gaap:EmployeeStockOptionMember2025-01-012025-03-310001919246us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310001919246us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310001919246pths:LNHCInc.Memberus-gaap:SeriesAPreferredStockMember2025-07-012025-07-010001919246pths:LNHCInc.Memberus-gaap:SeriesAPreferredStockMember2025-07-010001919246pths:LNHCInc.Member2025-10-012025-12-310001919246pths:LNHCInc.Memberus-gaap:DevelopedTechnologyRightsMember2025-07-012025-07-010001919246pths:LNHCInc.Memberpths:SatoLicenseMember2025-07-012025-07-010001919246pths:ReedyCreekMemberpths:LNHCInc.Member2025-07-010001919246pths:LNHCInc.Member2026-01-012026-03-310001919246pths:LNHCInc.Member2025-01-012025-03-310001919246pths:ManufacturingAndLaboratoryEquipmentMember2025-12-310001919246us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2026-03-310001919246us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-12-310001919246us-gaap:FurnitureAndFixturesMember2026-03-310001919246us-gaap:FurnitureAndFixturesMember2025-12-310001919246us-gaap:ComputerEquipmentMember2025-12-310001919246us-gaap:LeaseholdImprovementsMember2026-03-310001919246us-gaap:LeaseholdImprovementsMember2025-12-310001919246us-gaap:ConstructionInProgressMember2026-03-310001919246us-gaap:ConstructionInProgressMember2025-12-310001919246us-gaap:DevelopedTechnologyRightsMember2026-03-310001919246us-gaap:DevelopedTechnologyRightsMember2025-12-310001919246pths:SatoLicenseNetOfImpairmentMember2026-03-310001919246pths:SatoLicenseNetOfImpairmentMember2025-12-310001919246pths:XepiTransactionIntangibleAssetMember2026-03-310001919246pths:XepiTransactionIntangibleAssetMember2025-12-310001919246pths:XeglyzeTransactionIntangibleAssetMember2026-03-310001919246pths:XeglyzeTransactionIntangibleAssetMember2025-12-310001919246pths:WebsiteDevelopmentMember2026-03-310001919246pths:WebsiteDevelopmentMember2025-12-310001919246pths:ReedyCreekLicenseMember2026-03-310001919246pths:ReedyCreekLicenseMember2025-12-310001919246pths:ZELSUVMILicenseMember2026-03-310001919246pths:ZELSUVMILicenseMember2025-12-310001919246pths:XepiLicenseMember2026-03-310001919246pths:XepiLicenseMember2025-12-310001919246pths:SatoLicenseMember2026-03-310001919246pths:SatoLicenseMember2025-12-310001919246srt:MaximumMemberpths:BiofronteraInc.Member2025-11-062025-11-060001919246pths:BiofronteraInc.Member2025-11-062025-11-060001919246pths:ContingentConsiderationAchievementOfCommercialQuantitiesMemberpths:BiofronteraInc.Member2025-11-062025-11-060001919246pths:BiofronteraInc.Member2025-11-060001919246pths:ContingentConsiderationAchievementOfSalesBasedMilestonesMemberpths:BiofronteraInc.Member2025-11-062025-11-060001919246pths:FerrerInternacionalS.A.AndInterquimS.A.U.Memberpths:FerrerLicenseAgreementMember2025-11-062025-11-060001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMemberpths:BiofronteraInc.Member2025-01-012025-12-310001919246pths:AssetAcquisitionAllocatedPurchasePriceMemberpths:XEPITransactionMemberpths:BiofronteraInc.Member2025-01-012025-12-310001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMemberpths:BiofronteraInc.Memberpths:ContingentConsiderationAchievementOfCommercialQuantitiesMember2025-01-012025-12-310001919246pths:AssetAcquisitionAllocatedPurchasePriceMemberpths:XEPITransactionMemberpths:BiofronteraInc.Memberpths:ContingentConsiderationAchievementOfCommercialQuantitiesMember2025-01-012025-12-310001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMemberpths:BiofronteraInc.Memberpths:ContingentConsiderationAchievementOfSalesBasedMilestonesMember2025-01-012025-12-310001919246pths:AssetAcquisitionAllocatedPurchasePriceMemberpths:XEPITransactionMemberpths:BiofronteraInc.Memberpths:ContingentConsiderationAchievementOfSalesBasedMilestonesMember2025-01-012025-12-310001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMemberpths:FerrerMemberpths:ContingentConsiderationAcceptanceOfInitialAPIPurchaseMember2025-01-012025-12-310001919246pths:AssetAcquisitionAllocatedPurchasePriceMemberpths:XEPITransactionMemberpths:FerrerMemberpths:ContingentConsiderationAcceptanceOfInitialAPIPurchaseMember2025-01-012025-12-310001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMemberpths:VariousMember2025-01-012025-12-310001919246pths:AssetAcquisitionAllocatedPurchasePriceMemberpths:XEPITransactionMemberpths:VariousMember2025-01-012025-12-310001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMember2025-01-012025-12-310001919246pths:AssetAcquisitionAllocatedPurchasePriceMemberpths:XEPITransactionMember2025-01-012025-12-310001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMemberpths:FerrerMember2025-12-310001919246pths:AssetAcquisitionAllocatedPurchasePriceMemberpths:XEPITransactionMemberpths:FerrerMember2025-12-310001919246pths:XepiTransactionIntangibleAssetMemberpths:XEPITransactionMember2025-11-060001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMemberpths:BiofronteraInc.Memberpths:ContingentConsiderationAchievementOfCommercialQuantitiesMember2025-11-062025-11-060001919246pths:AssetAcquisitionContractualAmountMemberpths:XEPITransactionMemberpths:FerrerMemberpths:ContingentConsiderationAcceptanceOfInitialAPIPurchaseMember2025-11-062025-11-060001919246pths:XEPITransactionMember2025-11-060001919246pths:XEPITransactionMember2025-12-310001919246pths:XEGLYZEAssetPurchaseAgreementMember2025-11-202025-12-290001919246pths:XEGLYZEAssetPurchaseAgreementMember2025-11-202025-11-200001919246pths:XEGLYZEAssetPurchaseAgreementMember2025-12-292025-12-290001919246us-gaap:IntellectualPropertyMemberpths:XEGLYZEAssetPurchaseAgreementMember2025-12-290001919246us-gaap:DevelopedTechnologyRightsMember2026-01-012026-03-310001919246pths:SatoLicenseMember2026-03-310001919246pths:SatoLicenseMember2026-01-012026-03-310001919246pths:XepiTransactionIntangibleAssetMember2026-01-012026-03-310001919246pths:XeglyzeTransactionIntangibleAssetMember2026-01-012026-03-310001919246pths:WebsiteDevelopmentMember2026-01-012026-03-310001919246pths:SatoLicenseMember2025-01-012025-12-310001919246pths:DevelopedTechnologyMember2026-03-310001919246pths:SatoMember2026-01-012026-03-310001919246pths:SatoMember2026-03-310001919246pths:SatoMember2026-04-012026-03-310001919246pths:SatoMember2027-04-012026-03-3100019192462026-01-120001919246us-gaap:SecuredDebtMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberus-gaap:LineOfCreditMember2026-03-310001919246us-gaap:SecuredDebtMemberpths:DebtInstrumentRepaymentPeriodOneMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberus-gaap:LineOfCreditMember2026-01-122026-01-120001919246us-gaap:SecuredDebtMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberpths:DebtInstrumentRepaymentPeriodOneMembersrt:MinimumMemberus-gaap:LineOfCreditMember2026-01-122026-01-120001919246us-gaap:SecuredDebtMemberpths:DebtInstrumentRepaymentPeriodTwoMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberus-gaap:LineOfCreditMember2026-01-122026-01-120001919246us-gaap:SecuredDebtMemberpths:DebtInstrumentRepaymentPeriodOneMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberus-gaap:LineOfCreditMember2026-01-120001919246us-gaap:SecuredDebtMemberpths:DebtInstrumentRepaymentPeriodTwoMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberus-gaap:LineOfCreditMember2026-01-120001919246us-gaap:SecuredDebtMemberpths:DebtInstrumentRepaymentPeriodThreeMemberpths:VentureLoanAndSecurityAgreementTermLoansMemberus-gaap:LineOfCreditMember2026-01-120001919246pths:HorizonWarrantsMember2026-01-120001919246pths:HorizonWarrantsMember2026-01-122026-01-120001919246pths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-11-060001919246pths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246us-gaap:LineOfCreditMember2025-11-060001919246pths:AssetBasedLoanFacilityMember2025-11-060001919246pths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-12-010001919246pths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-12-170001919246pths:LigandMemberpths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246pths:ConvertibleInvestorsMemberpths:ConvertibleNotesMembersrt:MinimumMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246pths:ConvertibleInvestorsMemberpths:ConvertibleNotesMembersrt:MaximumMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246pths:XEPIMemberpths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-11-060001919246pths:ZELSUVMIMemberpths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-11-060001919246pths:ConvertibleNotesMemberus-gaap:DebtInstrumentRedemptionPeriodOneMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246pths:ConvertibleNotesMembersrt:MinimumMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246pths:ConvertibleNotesMembersrt:MaximumMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246pths:ConvertibleNotesMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246pths:HorizonWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2026-01-120001919246pths:HorizonWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-01-120001919246pths:HorizonWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2026-01-120001919246pths:HorizonWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2026-01-120001919246pths:HorizonWarrantsMemberpths:MeasurementInputWeightedAverageFairValuePerOptionMember2026-01-120001919246us-gaap:SecuredDebtMemberpths:VentureLoanAndSecurityAgreementTermLoansFinalPaymentMemberus-gaap:LineOfCreditMember2026-03-310001919246us-gaap:SecuredDebtMemberpths:VentureLoanAndSecurityAgreementTermLoansFinalPaymentMemberus-gaap:LineOfCreditMember2026-01-120001919246us-gaap:SecuredDebtMemberpths:VentureLoanAndSecurityAgreementMemberus-gaap:LineOfCreditMember2026-03-310001919246us-gaap:SecuredDebtMemberpths:VentureLoanAndSecurityAgreementMemberus-gaap:LineOfCreditMember2026-01-120001919246us-gaap:ConvertibleDebtMember2025-12-310001919246us-gaap:ConvertibleDebtMember2026-01-012026-03-310001919246us-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberpths:MeasurementInputPaidInKindPeriodMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberpths:MeasurementInputPaidInKindPeriodMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputConversionPriceMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputConversionPriceMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario1Memberus-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario2Memberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario2Memberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario2Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario2Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario2Memberpths:MeasurementInputProbabilityMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario2Memberpths:MeasurementInputProbabilityMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario2Memberpths:MeasurementInputYieldCurveMemberus-gaap:ConvertibleDebtMember2026-03-310001919246pths:ConvertibleNotesMemberpths:ValuationTechniqueScenario2Memberpths:MeasurementInputYieldCurveMemberus-gaap:ConvertibleDebtMember2025-12-310001919246pths:FerrerLicenseAgreementMemberpths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-11-060001919246pths:FerrerLicenseAgreementMemberpths:ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2025-11-062025-11-060001919246pths:ReedyCreekPurchaseAgreementMemberpths:ReedyCreekMemberpths:NovanMember2019-04-290001919246pths:ReedyCreekPurchaseAgreementMemberpths:ReedyCreekMembersrt:MinimumMemberpths:NovanMember2019-04-292019-04-290001919246pths:ReedyCreekPurchaseAgreementMemberpths:ReedyCreekMembersrt:MaximumMemberpths:NovanMember2019-04-292019-04-290001919246pths:ReedyCreekPurchaseAgreementMemberpths:ReedyCreekMemberpths:NovanMember2019-04-292019-04-290001919246pths:UNCLicenseAgreementU.S.PatentsMember2026-03-310001919246pths:OriginalUNCLicenseAgreementU.S.PatentsMember2026-03-310001919246pths:U.S.PatentsCoveringZELSUVMIMember2026-03-310001919246pths:U.S.PatentsCoveringZELSUVMIMember2026-01-012026-03-310001919246pths:LigandMemberpths:LigandAssignmentAgreementAmendmentMember2025-11-060001919246pths:ZELSUVMILicenseMemberpths:LigandRoyaltyAgreementMemberpths:LigandMemberpths:PriorToTheExpirationOfInitialRoyaltyTermMember2026-01-012026-03-310001919246pths:ZELSUVMILicenseMemberpths:LigandRoyaltyAgreementMemberpths:LigandMemberpths:AfterTheExpirationOfInitialRoyaltyTermMember2026-01-012026-03-310001919246pths:ZELSUVMILicenseMemberpths:LigandRoyaltyAgreementMemberpths:LigandMemberpths:FirstCommercialSaleMember2026-01-012026-03-310001919246pths:ZELSUVMILicenseMemberpths:LigandRoyaltyAgreementMemberpths:LigandMemberpths:OccurrenceOfObtaining35000ThresholdInNetSalesForFourConsecutiveQuartersMember2026-01-012026-03-310001919246pths:ZELSUVMILicenseMemberpths:LigandRoyaltyAgreementMemberpths:LigandMember2026-01-012026-03-310001919246pths:UNCLicenseMemberpths:UNCLicenseAgreementMemberpths:UNCMember2026-03-310001919246pths:UNCLicenseMemberpths:UNCLicenseAgreementMemberpths:UNCMember2026-01-012026-03-310001919246pths:ZELSUVMILicenseMemberpths:ZELSUVMIRoyaltyAgreementMemberpths:NomisRoyaltyVestLCMember2025-07-012025-07-010001919246pths:ZELSUVMILicenseMemberpths:ZELSUVMIRoyaltyAgreementMemberpths:NomisRoyaltyVestLCMemberpths:PriorToTheExpirationOfInitialRoyaltyTermMember2025-07-012025-07-010001919246pths:ZELSUVMILicenseMemberpths:ZELSUVMIRoyaltyAgreementMemberpths:NomisRoyaltyVestLCMemberpths:AfterTheExpirationOfInitialRoyaltyTermMember2025-07-012025-07-010001919246pths:ChannelCoveredProductsLicenseMemberpths:ChannelProductsRoyaltyAgreementMemberpths:NRVLigandMadisonMember2025-07-012025-07-010001919246pths:ChannelCoveredProductsLicenseMemberpths:ChannelProductsRoyaltyAgreementMemberpths:NomisRoyaltyVestLCMemberpths:PriorToTheExpirationOfInitialRoyaltyTermMember2025-07-012025-07-010001919246pths:ChannelCoveredProductsLicenseMemberpths:ChannelProductsRoyaltyAgreementMemberpths:LigandMemberpths:PriorToTheExpirationOfInitialRoyaltyTermMember2025-07-012025-07-010001919246pths:ChannelCoveredProductsLicenseMemberpths:ChannelProductsRoyaltyAgreementMemberpths:MaidsonMemberpths:PriorToTheExpirationOfInitialRoyaltyTermMember2025-07-012025-07-010001919246pths:ChannelCoveredProductsLicenseMemberpths:ChannelProductsRoyaltyAgreementMemberpths:NomisRoyaltyVestLCMemberpths:AfterTheExpirationOfInitialRoyaltyTermMember2025-07-012025-07-010001919246pths:ChannelCoveredProductsLicenseMemberpths:ChannelProductsRoyaltyAgreementMemberpths:LigandMemberpths:AfterTheExpirationOfInitialRoyaltyTermMember2025-07-012025-07-010001919246pths:ChannelCoveredProductsLicenseMemberpths:ChannelProductsRoyaltyAgreementMemberpths:MaidsonMemberpths:AfterTheExpirationOfInitialRoyaltyTermMember2025-07-012025-07-010001919246pths:ReedyCreekLicenseMemberus-gaap:MeasurementInputDiscountRateMember2026-03-310001919246pths:ZELSUVMILicenseMemberus-gaap:MeasurementInputDiscountRateMember2026-03-310001919246pths:ChannelCoveredProductsLicenseMemberus-gaap:MeasurementInputDiscountRateMember2026-03-310001919246pths:XepiLicenseMemberus-gaap:MeasurementInputDiscountRateMember2026-03-310001919246pths:SatoLicenseMemberus-gaap:MeasurementInputDiscountRateMember2026-03-310001919246pths:ReedyCreekLicenseMemberpths:MeasurementInputProbabilityOfSuccessMember2026-03-310001919246pths:ZELSUVMILicenseMemberpths:MeasurementInputProbabilityOfSuccessMember2026-03-310001919246pths:ChannelCoveredProductsLicenseMemberpths:MeasurementInputProbabilityOfSuccessMember2026-03-310001919246pths:XepiLicenseMemberpths:MeasurementInputProbabilityOfSuccessMember2026-03-310001919246pths:SatoLicenseMemberpths:MeasurementInputProbabilityOfSuccessMember2026-03-310001919246us-gaap:LicenseMember2025-12-310001919246pths:ReedyCreekLicenseMember2026-01-012026-03-310001919246pths:ZELSUVMILicenseMember2026-01-012026-03-310001919246pths:XepiLicenseMember2026-01-012026-03-310001919246pths:SatoLicenseMember2026-01-012026-03-310001919246us-gaap:LicenseMember2026-01-012026-03-310001919246us-gaap:LicenseMember2026-03-3100019192462021-11-2300019192462021-01-180001919246pths:Months110Member2021-11-232021-11-230001919246pths:Months1112Member2021-11-232021-11-2300019192462021-11-232021-11-230001919246us-gaap:LetterOfCreditMember2021-11-2300019192462024-06-122024-06-1200019192462024-06-1100019192462024-06-1200019192462025-04-160001919246pths:CEFPurchaseAgreementMember2024-07-260001919246pths:CEFPurchaseAgreementMember2024-10-022024-10-020001919246pths:CEFPurchaseAgreementMember2024-10-182024-10-180001919246pths:WarrantsToPurchaseCommonSharesIssuedMemberus-gaap:IPOMember2024-02-210001919246pths:WarrantsToPurchaseCommonSharesIssuedMemberus-gaap:IPOMember2024-02-212024-02-210001919246pths:WarrantsToPurchaseCommonSharesIssuedMemberus-gaap:IPOMember2025-09-180001919246pths:WarrantsToPurchaseCommonSharesIssuedMemberus-gaap:IPOMember2025-09-182025-09-180001919246pths:TwoThousandTwentyThreePlanMemberus-gaap:EmployeeStockOptionMember2026-01-012026-03-310001919246us-gaap:ResearchAndDevelopmentExpenseMember2026-01-012026-03-310001919246us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-03-310001919246us-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310001919246us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001919246us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001919246us-gaap:EmployeeStockOptionMember2025-01-012025-03-310001919246us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310001919246us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310001919246us-gaap:EmployeeStockOptionMember2026-03-310001919246us-gaap:RestrictedStockUnitsRSUMember2026-03-310001919246us-gaap:RestrictedStockUnitsRSUMember2025-12-310001919246us-gaap:RestrictedStockUnitsRSUMember2024-12-310001919246us-gaap:RestrictedStockUnitsRSUMember2025-03-3100019192462024-02-152024-02-150001919246pths:CommercialOperationsSegmentMember2026-01-012026-03-310001919246pths:CommercialOperationsSegmentMember2025-01-012025-03-310001919246pths:ResearchAndDevelopmentOperationsSegmentMember2026-01-012026-03-310001919246pths:ResearchAndDevelopmentOperationsSegmentMember2025-01-012025-03-310001919246pths:CommercialOperationsSegmentMember2026-03-310001919246pths:CommercialOperationsSegmentMember2025-12-310001919246pths:ResearchAndDevelopmentOperationsSegmentMember2026-03-310001919246pths:ResearchAndDevelopmentOperationsSegmentMember2025-12-31\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\nFORM 10-Q\n\n(Mark One)\n\n☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the quarterly period ended March 31, 2026\n\nor\n\n☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the transition period from ______________to _______________.\n\nCommission File Number: 001-41964\n\nPelthos Therapeutics Inc.\n\n(Exact name of registrant as specified in its charter)\n\nNevada\n\n86-3335449\n\n(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)\n\nPelthos Therapeutics Inc.\n\n4020 Stirrup Creek Drive, Suite 110\n\nDurham, NC 27703\n\n(Address of principal executive offices) (Zip Code)\n\n(919) 908-2400\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each classTrading symbol(s)Name of each exchange on which registered\n\nCommon Stock, par value $0.0001 per share\n\nPTHS\n\nThe NYSE American LLC\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☐\n\nAccelerated filer ☐\n\nNon-accelerated filer ☒\n\nSmaller reporting company ☒\n\nEmerging growth company ☒\n\nIf an emerging growth company, indicate by check-mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nThe number of shares of the registrant’s common stock outstanding as of May 11, 2026 is 3,475,645.\n\n1\n\nPELTHOS THERAPEUTICS INC.\n\nQUARTERLY REPORT ON FORM 10-Q\n\nFor the Quarter Ended March 31, 2026\n\nPage\nNumber\n\n[PART I: FINANCIAL INFORMATION](#i93938272fdf54be2822336441b8883df_678)\n\n[3](#i93938272fdf54be2822336441b8883df_678)\n\n[Item 1. Financial Statements (unaudited)](#i93938272fdf54be2822336441b8883df_788)\n\n[3](#i93938272fdf54be2822336441b8883df_788)\n\n[Condensed Consolidated Balance Sheets](#i93938272fdf54be2822336441b8883df_794)\n\n[3](#i93938272fdf54be2822336441b8883df_794)\n\n[Condensed Consolidated Statements of Operations and Comprehensive Loss](#i93938272fdf54be2822336441b8883df_801)\n\n[4](#i93938272fdf54be2822336441b8883df_801)\n\n[Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit](#i93938272fdf54be2822336441b8883df_808))\n\n[5](#i93938272fdf54be2822336441b8883df_808)\n\n[Condensed Consolidated Statements of Cash Flows](#i93938272fdf54be2822336441b8883df_826)\n\n[6](#i93938272fdf54be2822336441b8883df_826)\n\n[Notes to Condensed Consolidated Financial Statements](#i93938272fdf54be2822336441b8883df_858)\n\n[8](#i93938272fdf54be2822336441b8883df_858)\n\n[Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations](#i93938272fdf54be2822336441b8883df_549755814922)\n\n[47](#i93938272fdf54be2822336441b8883df_549755814922)\n\n[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#i93938272fdf54be2822336441b8883df_549755815030)\n\n[71](#i93938272fdf54be2822336441b8883df_549755815030)\n\n[Item 4. Controls and Procedures](#i93938272fdf54be2822336441b8883df_549755815051)\n\n[71](#i93938272fdf54be2822336441b8883df_549755815051)\n\n[PART II. OTHER INFORMATION](#i93938272fdf54be2822336441b8883df_1174)\n\n[73](#i93938272fdf54be2822336441b8883df_1174)\n\n[Item 1. Legal Proceedings](#i93938272fdf54be2822336441b8883df_549755815072)\n\n[73](#i93938272fdf54be2822336441b8883df_549755815072)\n\n[Item 1A. Risk Factors](#i93938272fdf54be2822336441b8883df_1196)\n\n[73](#i93938272fdf54be2822336441b8883df_1196)\n\n[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#i93938272fdf54be2822336441b8883df_549755815091)\n\n[73](#i93938272fdf54be2822336441b8883df_549755815091)\n\n[Item 3. Defaults Upon Senior Securities](#i93938272fdf54be2822336441b8883df_1236)\n\n[74](#i93938272fdf54be2822336441b8883df_1236)\n\n[Item 4. Mine Safety Disclosures](#i93938272fdf54be2822336441b8883df_549755815102)\n\n[74](#i93938272fdf54be2822336441b8883df_549755815102)\n\n[Item 5. Other Information](#i93938272fdf54be2822336441b8883df_549755815113)\n\n[74](#i93938272fdf54be2822336441b8883df_549755815113)\n\n[Item 6. Exhibits](#i93938272fdf54be2822336441b8883df_549755815131)\n\n[75](#i93938272fdf54be2822336441b8883df_549755815131)\n\n[SIGNATURES](#i93938272fdf54be2822336441b8883df_549755815144)\n\n[76](#i93938272fdf54be2822336441b8883df_549755815144)\n\n2\n\nPART I: FINANCIAL INFORMATION"}